CX3CL1 - C-X3-C motif chemokine ligand 1 Gene
Also Known as NTN; NTT; CXC3; CXC3C; SCYD1; ABCD-3; C3Xkine; fractalkine; neurotactin
生物種: Homo sapiens
About CX3CL1
This gene has 4 transcripts (splice variants), 155 orthologues and 25 paralogues. Broad expression in brain (RPKM 40.1), lung (RPKM 37.8) and 21 other tissues.
Summary
This gene belongs to the CX3C subgroup of chemokines, characterized by the number of Amino acids located between the conserved cysteine residues. This is the only member of the CX3C subgroup, which contains three Amino acids between cysteine residues, resulting in a Cys-X-X-X-Cys configuration. The encoded protein contains an extended mucin-like stalk with a chemokine domain on top, and exists in both a membrane-anchored form where it acts as a binding molecule, or, in soluble form, as a chemotactic cytokine. The mature form of this protein can be cleaved at the cell surface, yielding different soluble forms that can interact with the G-protein coupled receptor, C-X3-C motif Chemokine Receptor 1 gene product. This gene plays a role in a wide range of diseases, including Cancer, vasculitis, neuropathies, atherosclerosis, inflammatory diseases, and in human immunodeficiency virus infections. [provided by RefSeq, Sep 2017]
CX3CL1 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001304392.3 | NP_001291321.1 | fractalkine isoform 2 |
| NM_002996.6 | NP_002987.1 | fractalkine isoform 1 precursor |
| Molecular Function GO Annotation | Evidence | 参考文献 | 由来 |
|---|---|---|---|
| enables CX3C chemokine receptor binding |
IDA
IDA: Inferred from direct assay
|
10415068 | GOA |
| enables CXCR1 chemokine receptor binding |
IPI
IPI: Inferred from physical interaction
|
10187784 | GOA |
| enables chemoattractant activity |
IMP
IMP: Inferred from mutant phenotype
|
10899174 | GOA |
| enables chemokine activity |
IDA
IDA: Inferred from direct assay
|
21829356 | GOA |
| enables chemokine activity |
IGI
IGI: Inferred from genetic interaction
|
10415068 | GOA |
| enables integrin binding |
IDA
IDA: Inferred from direct assay
|
23125415 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
9931005 | GOA |
| Cellular Component GO Annotation | Evidence | 参考文献 | 由来 |
|---|---|---|---|
| located in cell surface |
IDA
IDA: Inferred from direct assay
|
12714508 | GOA |
| located in extracellular region |
IDA
IDA: Inferred from direct assay
|
10415068 | GOA |
| located in extracellular region |
IMP
IMP: Inferred from mutant phenotype
|
10899174 | GOA |
| located in membrane |
IDA
IDA: Inferred from direct assay
|
10899174 | GOA |
CX3CL1 Protein Structure
IL8: Small cytokines (intecrine/chemokine), interleukin-8 like (36 - 89)
- 0
- 100
- 200
- 300
- 397 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fractalkine |
|
CX3CL1 Protein-protein interaction Information
|
Type
|
タンパク質名 | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | 参考文献 |
|---|---|---|---|---|---|---|---|
|
Intra
|
CX3CL1 | P78423 | ITGB3 | Homo sapiens | P05106 | 24789099 | |
|
Intra
|
CX3CL1 | P78423 | ITGB3 | Homo sapiens | P05106 | 23125415 | |
|
Intra
|
CX3CL1 | P78423 | ITGB3 | Homo sapiens | P05106 | 24789099 |
Recombinant CX3CL1 Proteins
| 製品番号 | 製品名 | アクセッション番号 | 純度 |
|---|---|---|---|
| HY-P7180 | Fractalkine/CX3CL1 Protein, Human | P78423 (Q25-G100) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P7355 | Fractalkine/CX3CL1 Protein, Human (S199N, CHO) | P78423 (Q25-R339, S199N) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P72685 | Fractalkine/CX3CL1 Protein, Human (315a.a, HEK293, His) | P78423 (Q25-R339) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P76938 | Fractalkine/CX3CL1 Protein, Cynomolgus (HEK293, Fc) | EHH60415.1 (Q25-G100) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P76939 | Fractalkine/CX3CL1 Protein, Cynomolgus (HEK293, His) | EHH60415.1 (Q25-G100) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78937 | Fractalkine/CX3CL1 Protein, Human (Biotinylated, HEK293, His, Avi) | P78423/AAH01163 (Q25-Q341) | ≥ 95%, as determined by reducing SDS-PAGE. |
CX3CL1 抗体
| 製品番号 | 製品名 | アプリケーション | 反応性 |
|---|---|---|---|
| HY-P811043 | Fractalkine Antibody | WB, ICC/IF | Human, Mouse, Rat |
関連疾患
| Diseases | Alias | |
|---|---|---|
| Pityriasis Rosea |
|
|
| Vasculitis |
|
|
| Chorioretinitis |
|
|
| Encephalitis |
|
|
| Neuritis |
|
|
| Rheumatoid Arthritis |
|
|
| Chronic Cholangitis |
|
|
| Inflammatory Bowel Disease |
|
|
| Retinal Degeneration |
|
|
| Refractory Plasma Cell Neoplasm |
|
|
| Polycystic Lipomembranous Osteodysplasia With Sclerosing Leukoencephalopathy 1 |
|
|
| Systemic Lupus Erythematosus |
|
|
| Heart Disease |
|
|
| Dermatitis, Atopic |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
| Nervous System Disease |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| 生物種 | Symbol | 由来 | ID |
|---|---|---|---|
| Felis catus | CX3CL1 | VGNC | VGNC:61296 |
| Mus musculus | CX3CL1 | MGD | MGI:1097153 |
| Rattus norvegicus | CX3CL1 | RGD | RGD:620458 |
| Canis familiaris | CX3CL1 | VGNC | VGNC:39745 |
| Bos taurus | CX3CL1 | VGNC | VGNC:52190 |
| Macaca mulatta | CX3CL1 | VGNC | VGNC:71395 |
| Others | CX3CL1 | NCBI |